Skip to main content
All tenders

Delivery of Medicines for the National Oncology Institute Gliwice

Notice title: Sukcesywne dostawy leków dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej Curie Państwowego Instytutu Badawczego Oddziału w Gliwicach

Status
Active
Submission Deadline
11 days remaining
Location
Gliwice, Poland
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-635181-2026

Delivery of pharmaceutical products: successively over 24 months from contract conclusion or until the financial limit is reached; the contract expires upon reaching the limit or the end of the term, whichever occurs first. Details are included in the tender documents.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 635181-2026HTML
  • TED PDF — 635181-2026PDF
  • TED XML — 635181-2026XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Lots (3)

  • LOT-0001Orale Diät für präoperative Patientenbehandlung
  • LOT-0002Lieferung von Pemigatinib
  • LOT-0003Lieferung von verschiedenen pharmazeutischen Erzeugnissen

Additional details

EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context

Prefer a private session?